Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISEDRONATE vs RITLECITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISEDRONATE vs RITLECITINIB: Safety Overview

Metric RISEDRONATE RITLECITINIB
Total FAERS Reports 6,768 1,441
Deaths Reported 202 1
Death Rate 3.0% 0.1%
Hospitalizations 1,825 47
Average Patient Age 68.0 yrs 34.7 yrs
% Female Patients 92.3% 65.0%
FDA Approval Date Apr 14, 2000 Jun 23, 2023
Manufacturer Aurobindo Pharma Limited U.S. Pharmaceuticals
Route ORAL ORAL
Marketing Status Discontinued Prescription